Changing epidemiology of Clostridium difficile-associated disease in children

Lacey Benson1, Xiaoyan Song, Joseph Campos

  • 1Case Western School of Medicine, Cleveland, OH, USA.

Insights

Pediatric Clostridium difficile-associated disease (CDAD) incidence rose in emergency departments, particularly community-associated CDAD, while inpatient cases declined. This suggests changing disease characteristics in children, a previously low-risk group.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Microbiology

Background:

  • Clostridium difficile-associated disease (CDAD) is a significant healthcare-associated infection.
  • While historically considered low-risk, pediatric populations may be experiencing shifts in CDAD incidence and characteristics.
  • Understanding temporal trends in pediatric CDAD is crucial for public health and clinical management.

Purpose of the Study:

  • To investigate the temporal trends in the incidence rate of Clostridium difficile-associated disease (CDAD) within a pediatric patient population.
  • To analyze changes in CDAD rates across different healthcare settings (inpatient, outpatient, emergency department, NICU) over a five-year period.

Main Methods:

  • An observational, retrospective cohort study was conducted.
  • Data were collected from pediatric patients at Children's National Medical Center between July 2001 and June 2006.
  • Poisson regression analysis was used to assess temporal trends in CDAD incidence rates.

Main Results:

  • A total of 513 pediatric patients tested positive for C. difficile toxin.
  • The incidence of community-associated CDAD significantly increased in the emergency department (1.18 to 2.47 cases per 1,000 visits, P=.02).
  • Conversely, inpatient CDAD incidence decreased (1.024 to 0.680 cases per 1,000 patient-days, P=.004).
  • CDAD was also detected in 22 neonates in the NICU.

Conclusions:

  • A notable increase in community-acquired CDAD was observed in pediatric emergency department visits.
  • The findings indicate evolving patterns of CDAD in children, challenging previous assumptions about their low-risk status.
  • Further research is needed to understand these changing disease burdens and identify specific risk factors in pediatric populations.
Abstract

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...